Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 20,000 shares at $0.13 ($3K) on 2016-10-07, disclosed to the SEC on 2016-10-11.
Seasonal purchase ($3k) by CEO, 10% Owner — this insider has traded LXRP in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.12 | 5,000 | $600 | 23.5% |
| 2 | $0.13 | 5,000 | $650 | 25.5% |
| 3 | $0.13 | 10,000 | $1K | 51.0% |
| Total | $0.13 avg | 20,000 | $3K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |
| LXRP | BUY | 2016-08-25 | $3K | — | Filing → |